Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Holding GALT?
Track your performance easily

Galectin Therapeutics (GALT) Financial Statements

561 Followers

Galectin Therapeutics Financial Overview

Galectin Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.783; its P/E ratio is -3.59; Galectin Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.37M$ -10.44M$ -9.15M$ -9.59M$ -9.11M
EBITDA$ -12.36M$ -10.43M$ -9.14M$ -9.59M$ -8.46M
Net Income Common Stockholders$ -12.44M$ -11.50M$ -10.06M$ -14.04M$ -9.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.60M$ 23.55M$ 25.66M$ 20.36M$ 17.97M
Total Assets$ 27.66M$ 25.89M$ 28.20M$ 22.16M$ 20.08M
Total Debt$ 62.05M$ 51.32M$ 0.00$ 0.00$ 29.93M
Net Debt$ 36.45M$ 27.77M$ -25.66M$ -20.36M$ 11.96M
Total Liabilities$ 109.80M$ 96.98M$ 88.44M$ 73.04M$ 71.21M
Stockholders Equity$ -83.87M$ -72.81M$ -61.96M$ -52.60M$ -52.85M
Cash Flow-
Free Cash Flow$ -8.33M$ -12.11M$ -4.70M$ -7.64M$ -9.83M
Operating Cash Flow$ -8.33M$ -12.11M$ -4.70M$ -7.64M$ -9.83M
Investing Cash Flow-----
Financing Cash Flow$ 10.38M$ 10.00M$ 10.00M$ 10.03M$ 10.00M
Currency in USD

Galectin Therapeutics Earnings and Revenue History

Galectin Therapeutics Debt to Assets

Galectin Therapeutics Cash Flow

Galectin Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis